H.B. Fuller Company logo FUL - H.B. Fuller Company

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $66.80 DETAILS
HIGH: $73.00
LOW: $58.00
MEDIAN: $67.00
CONSENSUS: $66.80
UPSIDE: 23.96%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Moderate
Trading 30.6% above fair value
Current Price $53.89
Bear Case $33.00 38.8% downside ($33.00 - $53.89) / $53.89 = -38.8% $2.75 × 12x P/E
Fair Value $41.25 23.5% downside ($41.25 - $53.89) / $53.89 = -23.5% $2.75 × 15x P/E
Bull Case $49.50 8.1% downside ($49.50 - $53.89) / $53.89 = -8.1% $2.75 × 18x P/E

Adjust Assumptions

15.0x
2.75$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 19.6x

Plain-Language Summary

Applying a 15x P/E to adjusted EPS of $2.75, the base-case value is $41.25 per share. DDM cross-check: $52.35.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (15 analysts) $66.80
Analyst Range $58.00 – $73.00
Divergence from AlphaVal 38%

Warnings

Dividend-based valuation: $52.35 (above our primary estimate by 27%). Large gaps may signal the dividend doesn't reflect full earning power.
Wall Street's average price target is $66.80 (from 15 analysts). Our estimate is 38% below the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples